BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kojima Y, Kaga H, Hayashi S, Kitazawa T, Iimura Y, Ohno M, Yoshitsugu M, Fujiwara M, Hiyoshi T. Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study. World J Diabetes 2013; 4(1): 8-13 [PMID: 23493856 DOI: 10.4239/wjd.v4.i1.8]
URL: https://www.wjgnet.com/1948-9358/full/v4/i1/8.htm
Number Citing Articles
1
Jian Zhou, Zixuan Deng, Jingyi Lu, Hong Li, Xiuzhen Zhang, Yongde Peng, Yifei Mo, Yuqian Bao, Weiping Jia. Differential Therapeutic Effects of Nateglinide and Acarbose on Fasting and Postprandial Lipid Profiles: A Randomized TrialDiabetes Technology & Therapeutics 2015; 17(4): 229 doi: 10.1089/dia.2014.0299
2
Jordi Cortés, José Antonio González, María Nuncia Medina, Markus Vogler, Marta Vilaró, Matt Elmore, Stephen John Senn, Michael Campbell, Erik Cobo. Does evidence support the high expectations placed in precision medicine? A bibliographic reviewF1000Research 2018; 7: 30 doi: 10.12688/f1000research.13490.3
3
Jordi Cortés, José Antonio González, María Nuncia Medina, Markus Vogler, Marta Vilaró, Matt Elmore, Stephen John Senn, Michael Campbell, Erik Cobo. Does evidence support the high expectations placed in precision medicine? A bibliographic reviewF1000Research 2019; 7: 30 doi: 10.12688/f1000research.13490.4
4
Jordi Cortés, José Antonio González, María Nuncia Medina, Markus Vogler, Marta Vilaró, Matt Elmore, Stephen John Senn, Michael Campbell, Erik Cobo. Does evidence support the high expectations placed in precision medicine? A bibliographic reviewF1000Research 2018; 7: 30 doi: 10.12688/f1000research.13490.2
5
Jordi Cortés, José Antonio González, María Nuncia Medina, Markus Vogler, Marta Vilaró, Matt Elmore, Stephen John Senn, Michael Campbell, Erik Cobo. Does evidence support the high expectations placed in precision medicine? A bibliographic reviewF1000Research 2018; 7: 30 doi: 10.12688/f1000research.13490.1
6
Akira Kurozumi, Yosuke Okada, Hiroaki Satoh, Ikuo Inoue, Hiroko Chimori, Etsuko Akita, Toshihiko Shiraiwa, Yoshio Fujitani, Tomoya Mita, Masahiko Gosho, Hirotaka Watada. Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1Endocrine Journal 2018; 65(4): 415 doi: 10.1507/endocrj.EJ17-0386
7
Erin E. Mulvihill, Daniel J. Drucker. Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 InhibitorsEndocrine Reviews 2014; 35(6): 992 doi: 10.1210/er.2014-1035
8
Yoshitaka Akiyama, Tomoko Morita-Ohkubo, Natsuko Oshitani, Yuko Ohno, Yoshimasa Aso, Toshihiko Inukai, Masafumi Kakei, Masanobu Kawakami, Takuya Awata, Shigehiro Katayama, Masafumi Matsuda. Decreased glucagon levels and decreased insulin secretion after sitagliptin versus mitiglinide administration with similar glycemic levels following an oral glucose load: a randomized crossover pharmaceutical mechanistic studyDiabetology International 2016; 7(1): 25 doi: 10.1007/s13340-015-0207-1
9
Bo Ahrén, James E. Foley. Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolismDiabetologia 2016; 59(5): 907 doi: 10.1007/s00125-016-3899-2
10
Rim Nasri, Ola Abdelhedi, Ines Jemil, Ines Daoued, Khaled Hamden, Choumous Kallel, Abdelfattah Elfeki, Myriem Lamri-Senhadji, Ahmed Boualga, Moncef Nasri, Maha Karra-Châabouni. Ameliorating effects of goby fish protein hydrolysates on high-fat-high-fructose diet-induced hyperglycemia, oxidative stress and deterioration of kidney function in ratsChemico-Biological Interactions 2015; 242: 71 doi: 10.1016/j.cbi.2015.08.003
11
Jordi Cortés, José Antonio González, María Nuncia Medina, Markus Vogler, Marta Vilaró, Matt Elmore, Stephen John Senn, Michael Campbell, Erik Cobo. Does evidence support the high expectations placed in precision medicine? A bibliographic reviewF1000Research 2019; 7: 30 doi: 10.12688/f1000research.13490.5